Venetoclax and azacitidine in untreated patients with therapy-related acute myeloid leukemia, antecedent myelodysplastic syndromes or chronic myelomonocytic leukemia

被引：0

作者：

Pullarkat, Vinod ^{[1
,2
]}

Pratz, Keith W. ^{[3
]}

Doehner, Hartmut ^{[4
]}

Recher, Christian ^{[5
]}

Thirman, Michael J. ^{[6
]}

Dinardo, Courtney D.

Fenaux, Pierre ^{[8
,9
]}

Schuh, Andre C. ^{[10
]}

Wei, Andrew H. ^{[11
,12
]}

Pigneux, Arnaud ^{[13
]}

Jang, Jun-Ho ^{[14
]}

Juliusson, Gunnar ^{[15
]}

Miyazaki, Yasushi ^{[16
]}

Selleslag, Dominik ^{[17
]}

Arellano, Martha L. ^{[18
]}

Liu, Chenglong ^{[19
]}

Ridgeway, Jean A. ^{[19
]}

Potluri, Jalaja ^{[19
]}

Schuler, Jovita ^{[19
]}

Konopleva, Marina ^{[7
]}

机构：

[1] City Hope Comprehens Canc Ctr, Dept Hematol & Hematopoiet Cell Transplantat, Duarte, CA 91010 USA

[2] City Hope Comprehens Canc Ctr, Gehr Family Ctr Leukemia Res, Duarte, CA 91010 USA

[3] Univ Penn, Abramson Canc Ctr, Philadelphia, PA USA

[4] Ulm Univ Hosp, Dept Internal Med 3, Ulm, Germany

[5] CHU Toulouse, Toulouse, France

[6] Univ Chicago Med, Dept Med, Sect Hematol Oncol, Chicago, IL USA

[7] Montefiore Einstein Comprehens Canc Ctr, Bronx, NY USA

[8] Hop St Louis, Assistance Publ Hop Paris, Paris, France

[9] Univ Paris, Paris, France

[10] Princess Margaret Canc Ctr, Dept Med Oncol & Hematol, Toronto, ON, Canada

[11] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Peter MacCallum Canc Ctr, Melbourne, VIC, Australia

[12] Univ Melbourne, Melbourne, VIC, Australia

[13] CHU Bordeaux, Dept Hematol, Bordeaux, France

[14] Sungkyunkwan Univ, Samsung Med Ctr, Dept Hematol Oncol, Sch Med, Seoul, South Korea

[15] Skane Univ Hosp, Dept Hematol, Lund, Sweden

[16] Nagasaki Univ, Atom Bomb Dis Inst, Dept Hematol, Atom Bomb Dis & Hibakusha Med Unit, Nagasaki, Japan

[17] Algemeen Ziekenhuis St Jan, Brugge, Belgium

[18] Emory Univ, Sch Med, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA USA

[19] AbbVie Inc, N Chicago, IL USA

来源：

BLOOD CANCER JOURNAL | 2025年 / 15卷 / 01期

关键词：

D O I：

10.1038/s41408-025-01263-3

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：5

共 50 条

[31] Azacitidine or intensive chemotherapy for older patients with secondary or therapy-related acute myeloid leukemia
Dumas, Pierre-Yves
Bertoli, Sarah
Berard, Emilie
Mediavilla, Clemence
Yon, Edwige
Tavitian, Suzanne
Leguay, Thibaut
Huguet, Francoise
Forcade, Edouard
Milpied, Noel
Sarry, Audrey
Sauvezie, Mathieu
Bories, Pierre
Pigneux, Arnaud
Recher, Christian
ONCOTARGET, 2017, 8 (45) : 79126 - 79136
[32] Allogeneic Hematopoietic Stem Cell Transplantation for Therapy-Related Myelodysplastic Syndromes and Acute Myeloid Leukemia
Metheny, Leland, III
Saber, Wael
Weisdorf, Daniel J.
de Lima, Marcos
Callander, Natalie Scott
Litzow, Mark
Kebriaei, Partow
Hall, Aric C.
Sandmaier, Brenda M.
Zhang, Mei-Jie
Wang, Hai-Lin
Bo-Subait, Khalid
BLOOD, 2019, 134
[33] SAFETY PROFILE OF AZACITIDINE IN THE TREATMENT OF THERAPY-RELATED MYELODYSPLASTIC SYNDROMES/ACUTE MYELOID LEUKAEMIA
Minoia, C.
Sgherza, N.
Greco, G.
Buquicchio, C.
Loseto, G.
de Fazio, V.
Iacobazzi, A.
Rana, A.
Merchionne, F.
Tarantini, G.
Pavone, V.
Guarini, A.
HAEMATOLOGICA, 2014, 99 : 619 - 619
[34] The Impact of PHF6 Mutations in Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, and Acute Myeloid Leukemia
Chien, Kelly S.
Kanagal-Shamanna, Rashmi
Naqvi, Kiran
Sasaki, Koji
Alvarado, Yesid
Takahashi, Koichi
Kadia, Tapan M.
Borthakur, Gautam M.
Jabbour, Elias
Routbort, Mark
Pierce, Sherry A.
Soltysiak, Kelly
Kantarjian, Hagop M.
Garcia-Manero, Guillermo
Montalban-Bravo, Guillermo
BLOOD, 2019, 134
[35] Health-related quality of life (HRQoL) in patients with untreated higher-risk myelodysplastic syndromes (MDS), acute myeloid leukemia (AML), and chronic myelomonocytic leukemia (CMML) receiving glasdegib plus azacitidine (AZA).
Wang, Eunice S.
Bell, Timothy
Zeidan, Amer Methqal
Bhattacharyya, Helen
Kudla, Art
Chan, Geoffrey
Sekeres, Mikkael A.
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[36] Successful use of Palbociclib combined with Venetoclax and Azacitidine in an adult with refractory/relapsed therapy-related acute myeloid leukemia
Qu, Wenqiang
Lu, Jialing
Ji, Yujie
He, Zhewei
Hou, Mengjia
Li, Dongyang
Yang, Yan
Liu, Dan
Chen, Suning
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2024, 94 (04) : 635 - 639
[37] Effect of therapy-related acute myeloid leukemia on the outcome of patients with acute myeloid leukemia
Santo, Ana Espirito
Chacim, Sergio
Ferreira, Isabel
Leite, Luis
Moreira, Claudia
Pereira, Dulcineia
Brito, Margarida Dantas
Nunes, Marta
Domingues, Nelson
Oliveira, Isabel
Moreira, Ilidia
Martins, Angelo
Viterbo, Luisa
Mariz, Jose Mario
Medeiros, Rui
ONCOLOGY LETTERS, 2016, 12 (01) : 262 - 268
[38] Mutational analysis of therapy-related myelodysplastic syndromes and acute myelogenous leukemia
Shih, Alan H.
Chung, Stephen S.
Dolezal, Emily K.
Zhang, Su-Jiang
Abdel-Wahab, Omar I.
Park, Christopher Y.
Nimer, Stephen D.
Levine, Ross L.
Klimek, Virginia M.
HAEMATOLOGICA, 2013, 98 (06) : 908 - 912
[39] Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia
Litzow, Mark R.
Tarima, Sergey
Perez, Waleska S.
Bolwell, Brian J.
Cairo, Mitchell S.
Camitta, Bruce M.
Cutler, Corey S.
de Lima, Marcos
DiPersio, John F.
Gale, Robert Peter
Keating, Armand
Lazarus, Hillard M.
Luger, Selina
Marks, David I.
Maziarz, Richard T.
McCarthy, Philip L.
Pasquini, Marcelo C.
Phillips, Gordon L.
Rizzo, J. Douglas
Sierra, Jorge
Tallman, Martin S.
Weisdorf, Daniel J.
BLOOD, 2010, 115 (09) : 1850 - 1857
[40] Azathioprine: Association with Therapy-related Myelodysplastic Syndrome and Acute Myeloid Leukemia
Kwong, Yok-Lam
JOURNAL OF RHEUMATOLOGY, 2010, 37 (03) : 485 - 490

← 1 2 3 4 5 →